Related Experiment Video
Updated: Aug 11, 2026

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
Published on: January 20, 2016
Structural constraints for DNA recognition by Myc and other b-HLH-ZIP proteins: design of oncoprotein analogues
1Division of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
DNA recognition is a critical property of many transcription factors, some of which play important roles in human disease. Disruption of this recognition may profoundly influence the biology of these factors. One such factor, the Myc oncoprotein, utilizes a basic/helix-loop-helix/leucine zipper motif to recognize the DNA target CACGTG. As discussed here, this recognition appears to occur through recognition by one face of a basic region alpha helix utilizing amino acid side chains highly conserved among CACGTG binding proteins. This basic domain alpha helix, however, requires DNA binding for stabilization. To circumvent this energetic requirement, analogues were produced that introduce multiple alanines, displaying substantially increased spontaneous alpha helicity and significantly enhanced DNA affinity. These studies simplify our understanding of the structural constraints for DNA recognition by this family and may serve as a template for the design of small molecule transcription-targeted therapeutics.
Insights
Researchers engineered Myc oncoprotein analogues with enhanced DNA binding affinity. These modified proteins offer insights into transcription factor DNA recognition and potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- Transcription factors regulate gene expression and are crucial in human diseases.
- The Myc oncoprotein, a key factor, recognizes specific DNA sequences like CACGTG.
- Disrupting DNA recognition can significantly alter protein function.
Purpose of the Study:
- To investigate the structural basis of DNA recognition by the Myc oncoprotein.
- To engineer Myc analogues with improved DNA binding affinity.
- To explore potential therapeutic applications based on understanding DNA recognition mechanisms.
Main Methods:
- Structural analysis of the Myc basic region alpha helix involved in DNA binding.
- Design and synthesis of Myc analogues with increased alanine content.
- Assessment of spontaneous alpha helicity and DNA binding affinity of engineered analogues.
Main Results:
- The Myc basic region alpha helix requires DNA binding for stabilization.
- Engineered analogues with increased alanine content exhibited enhanced spontaneous alpha helicity.
- These modifications led to significantly increased DNA binding affinity.
Conclusions:
- The study elucidates structural constraints for DNA recognition by Myc and related proteins.
- Enhanced DNA affinity can be achieved by increasing the intrinsic alpha helicity of the DNA-binding domain.
- These findings provide a foundation for designing small molecule therapeutics targeting transcription factors.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
DNA Helicases
Single-Strand DNA Binding Proteins

